AI Article Synopsis

  • The study explores the complexities of bipolar disorder (BD) given its varying course among individuals and over time, emphasizing the need for better-targeted treatments and understanding of lifestyle factors.
  • An app called MinDag was developed to collect extensive data on BD-related symptoms and behaviors, focusing on areas like mood, sleep, and substance use, while addressing ethical and usability concerns.
  • Early testing of MinDag highlighted its effectiveness and user acceptance, positioning it as a valuable tool for ongoing research in BD at specialized facilities in Norway.

Article Abstract

Introduction: The illness course of bipolar disorder (BD) is highly heterogeneous with substantial variation between individuals with the same BD subtype and within individuals over time. This heterogeneity is not well-delineated and hampers the development of more targeted treatment. Furthermore, although lifestyle-related behaviors are believed to play a role in the illness course, such mechanisms are poorly understood. To address some of these knowledge gaps, we aimed to develop an app for collection of multi-dimensional longitudinal data on BD-relevant symptoms and lifestyle-related behaviors.

Methods: An app named MinDag was developed at the Norwegian Center for Mental Disorders Research in Oslo, Norway. The app was designed to tap into selected areas: mood, sleep, functioning/activities (social, occupational, physical exercise, leisure), substance use, emotional reactivity, and psychotic experiences. Ethical, security and usability issues were highly prioritized throughout the development and for the final app solution. We conducted beta- and pilot testing to eliminate technical problems and enhance usability and acceptability.

Results: The final version of MinDag comprises six modules; three which are presented for the user once daily (the Sleep module in the morning and the Mood and Functoning/Activities modules in the evening) and three which are presented once weekly (Substance Use, Emotional Reactivity, and Psychotic Experiences modules). In general, MinDag was well received in both in the beta-testing and the pilot study, and the participants provided valuable feedback that was taken into account in the final development. MinDag is now in use as part of the research protocol at the NORMENT center and in a specialized treatment unit for BD at Oslo University Hospital in Norway.

Discussion: We believe that MinDag will generate unique longitudinal data well suited for capturing the heterogeneity of BD and clarifying important unresolved issues such as how life-style related behavior may influence BD symptoms. Also, the experiences and knowledge derived from the development of MinDag may contribute to improving the security, acceptability, and benefit of digital tools in mental health.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354925PMC
http://dx.doi.org/10.3389/fmedt.2022.910533DOI Listing

Publication Analysis

Top Keywords

bipolar disorder
8
illness course
8
longitudinal data
8
substance emotional
8
emotional reactivity
8
reactivity psychotic
8
psychotic experiences
8
three presented
8
development mindag
8
mindag
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!